Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Jan 10, 2018 05:00 PM IST | Source: PTI

Lupin gets USFDA nod for generic version of Tamiflu capsules

The company has received final approval from the US drug regulator to market oseltamivir phosphate capsules, a generic version of Hoffman-La Roche Inc's Tamiflu capsules.

Drug major Lupin said it has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Tamiflu capsules, used in treating influenza.

The company has received final approval from the US drug regulator to market oseltamivir phosphate capsules, a generic version of Hoffman-La Roche Inc's Tamiflu capsules in strengths of 30 mg, 45 mg, and 75 mg, Lupin said in a statement.

Oseltamivir phosphate capsules are indicated for the treatment of influenza.

Close

As per IMS MAT October 2017 data, the capsules clocked annual sales of around USD 467.8 million in the US market.

Shares of Lupin closed 0.46 per cent up at Rs 925.05 on the BSE.

Are you happy with your current monthly income? Do you know you can double it without working extra hours or asking for a raise? Rahul Shah, one of the India's leading expert on wealth building, has created a strategy which makes it possible... in just a short few years. You can know his secrets in his FREE video series airing between 12th to 17th December. You can reserve your free seat here.
First Published on Jan 10, 2018 04:30 pm
Loading...
Follow us on
Available On